DionyMed Brands Inc.

DYME

CA25455C1005

Pharmaceuticals

Delayed Canadian Securities Exchange Other stock markets			5-day change	1st Jan Change
- ^CAD	-.--%		-70.00%	-.--%

2020	DionyMed Brands Inc. cancelled the acquisition of Pioneer Valley Extracts, LLC.	CI
2019	DionyMed Brands Inc. Announces Board Changes	CI

Dionymed Brands Inc. Reports Earnings Results for the Third Quarter Ended November 30, 2018

January 30, 2019

DionyMed Brands Inc. announced earnings results for the third quarter ended November 30, 2018. For the third quarter, the company announced sales was USD 6.950 million compared to USD 6.950 million a year ago. Net loss was USD 21.341 million compared to USD 21.341 million a year ago. For the nine months, sales was USD 10.026 million compared to USD 10.026 million a year ago. Net loss was USD 32.193 million compared to USD 32.193 million a year ago.

Latest news about DionyMed Brands Inc.

DionyMed Brands Inc. cancelled the acquisition of Pioneer Valley Extracts, LLC.	20-01-21	CI
DionyMed Brands Inc. Announces Board Changes	19-10-29	CI
DionyMed Brands Inc. Receives Notice of Default and Demand for Payment and Notice of Intention to Enforce Security	19-10-17	CI
DionyMed Brands Inc. Announces Executive Changes	19-10-16	CI
DionyMed Announces Executive Changes	19-09-17	CI
DionyMed Brands, Inc. Wins Three Provisional Licenses in Los Angeles and San Francisco	19-09-03	CI
Dionymed Brands Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-30	CI
DionyMed Brands Inc. announced that it has received CAD 2.62872 million in funding from Gotham Green Partners, LLC	19-07-31	CI
DionyMed Brands Inc. Signs Exclusive Distribution Agreement with Woah Candy Co	19-07-31	CI
DionyMed Brands Inc. completed the acquisition of select MMAC assets from MM Esperanza 2 LLC.	19-07-23	CI
Innovative Industrial Properties, Inc. completed the acquisition of The Los Angeles Cannabis Campus from DionyMed Brands Inc..	19-07-22	CI
Innovative Industrial Properties, Inc. entered into a definitive agreement with DionyMed Brands Inc. to acquire The Los Angeles Cannabis Campus for $13 million in a sale and leaseback transaction.	19-07-18	CI
DionyMed Brands Inc. Signs Exclusive Distribution Agreement with Fruit Slabs	19-07-11	CI
DionyMed Brands Inc. announced that it expects to receive CAD 32 million in funding from Alumina Partners Ltd.	19-06-05	CI
DionyMed Brands Inc. Reports Revenue Results for the First Quarter Ended March 31, 2019; Provides Revenue Guidance for the Second Quarter Ending June 30, 2019	19-05-31	CI
DionyMed Brands To Seek Acquisitions	19-05-31	CI
DionyMed Brands Inc. Auditor Raises 'Going Concern' Doubt	19-05-30	CI
DionyMed Brands Inc. Signs Exclusive Distribution Agreement with CBD Alive	19-05-09	CI
DionyMed Brands Inc. announced that it has received CAD 10.510651 million in funding	19-05-06	CI
Dionymed Brands Inc. Reports Earnings Results for the First Quarter of 2019	19-05-01	CI
DionyMed Brands Inc. will Change its Ticker to DYME from HMDEF	19-04-16	CI
DionyMed Brands Inc. announced that it expects to receive CAD 10.000001 million in funding	19-04-14	CI
DionyMed Brands Inc. Expands its Cannabis Brand Portfolio with Défoncé Chocolatier	19-04-10	CI
DionyMed Brands Inc. signed a binding term sheet to acquire select MMAC assets from MM Esperanza 2 LLC for $19 million.	19-03-19	CI
Dionymed Brands Inc. Reports Earnings Results for the Third Quarter Ended November 30, 2018	19-01-30	CI

Chart DionyMed Brands Inc.

Duration

Period

More charts

Company Profile

DionyMed Brands Inc is a Canada-based company, which offers a multi-state cannabis brands platform, supporting cultivators, manufacturers and brands in the medical and adult-use cannabis markets. The Company sells branded products in every category from flower to concentrates and edibles. It serves cannabis consumers through direct-to-consumer fulfillment and retail dispensary distribution with its brands.

Sector

Pharmaceuticals

More about the company

Sector Alternative Medicine

	1st Jan change	Capi.
DIONYMED BRANDS INC.	-.--%	363K
DONG-E-E-JIAO CO.,LTD.	+43.31%	6.29B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-16.99%	4.42B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+6.39%	3.3B
TASLY PHARMACEUTICAL GROUP CO., LTD	-13.10%	3.05B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-4.17%	2.47B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+45.47%	1.94B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-9.11%	1.66B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-2.09%	1.61B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.50%	1.54B

Alternative Medicine